Background: Metastatic pancreatic ductal adenocarcinoma (mPDAC) is an aggressive malignancy with a median overall survival (mOS) of between 8 and 11 months. With the use of modern chemotherapy ...

Metro-3 Phase 2 And Final Stretch Of Samruddhi Expressway Likely To Open On May 1; PM Modi May Inaugurate Projects According to sources, efforts are underway to inaugurate both projects through ...

Metro Line 3 Phase 2 Opens Up Connecting BKC To Worli; Over 26K Commuters Take Ride On Day 1 After Opening For Public Despite the seamless connectivity and the official launch on a weekend ...

Introduction Genetic and clinical evidence has shown that interleukin-33 plays a key role in the susceptibility and progression of asthma. The phase 2a FRONTIER-3 study ([NCT04570657][1]) investigated ...

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced ...

Background: Padeliporfin VTP has demonstrated safety and efficacy for UTUC treatment in a Phase 1 study (NCT03617003). Padeliporfin VTP is a combination product of a drug, padeliporfin administered IV ...

This project implements a remote control system for a crane operator, enabling users to monitor and adjust 3-phase AC induction motor performance parameters over a microcontroller and a UI through a ...

A Texas man who admitted to sneaking onto a Delta Air Lines flight last year and hiding in the bathroom was sentenced to three years of supervised release for unlawfully boarding an aircraft.

Ascletis Pharma’s acne pill has scored a phase 3 win, leading the Chinese biotech to claim the Sagimet Biosciences-sourced drug can hold its own against FDA-approved products like Seysara and ...

Grünenthal has moved its painkiller resiniferatoxin into phase 3 trials in patients with osteoarthritis, hoping to find an option that sidesteps the side effects and addictive potential of opioid ...

Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday.

PETACH TIKVA, Israel, June 17, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (" PolyPid ” or the " Company ”), a late-stage biopharma company aiming to improve surgical outcomes, today ...